These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20567091)

  • 41. Homozygous sequence variants in the NPR2 gene underlying Acromesomelic dysplasia Maroteaux type (AMDM) in consanguineous families.
    Irfanullah ; Umair M; Khan S; Ahmad W
    Ann Hum Genet; 2015 Jul; 79(4):238-44. PubMed ID: 25959430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C-Type natriuretic peptide/guanylate cyclase B system in rat osteogenic ROB-C26 cells and its down-regulation by dexamethazone.
    Suda M; Komatsu Y; Tanaka K; Yasoda A; Sakuma Y; Tamura N; Ogawa Y; Nakao K
    Calcif Tissue Int; 1999 Dec; 65(6):472-8. PubMed ID: 10594167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification.
    Tsuji T; Kondo E; Yasoda A; Inamoto M; Kiyosu C; Nakao K; Kunieda T
    Biochem Biophys Res Commun; 2008 Nov; 376(1):186-90. PubMed ID: 18775416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterisation and functional interrogation of a local natriuretic peptide system in rodent pituitaries, alphaT3-1 and LbetaT2 gonadotroph cells.
    Thompson IR; Chand AN; Jonas KC; Burrin JM; Steinhelper ME; Wheeler-Jones CP; McArdle CA; Fowkes RC
    J Endocrinol; 2009 Nov; 203(2):215-29. PubMed ID: 19666697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acromesomelic dysplasia, type maroteaux caused by novel loss-of-function mutations of the NPR2 gene: Three case reports.
    Wang W; Song MH; Miura K; Fujiwara M; Nawa N; Ohata Y; Kitaoka T; Kubota T; Namba N; Jin DK; Kim OH; Ozono K; Cho TJ
    Am J Med Genet A; 2016 Feb; 170A(2):426-434. PubMed ID: 26567084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism.
    Wagner BM; Robinson JW; Lin YW; Lee YC; Kaci N; Legeai-Mallet L; Potter LR
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33784257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway.
    Hakata T; Ueda Y; Yamashita T; Yamauchi I; Kosugi D; Sugawa T; Fujita H; Okamoto K; Fujii T; Taura D; Yasoda A; Akiyama H; Inagaki N
    Endocrinology; 2024 May; 165(7):. PubMed ID: 38752331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-type natriuretic peptide is a Schwann cell-derived factor for development and function of sensory neurones.
    Kishimoto I; Tokudome T; Horio T; Soeki T; Chusho H; Nakao K; Kangawa K
    J Neuroendocrinol; 2008 Nov; 20(11):1213-23. PubMed ID: 18752656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular and in silico analyses validates pathogenicity of homozygous mutations in the NPR2 gene underlying variable phenotypes of Acromesomelic dysplasia, type Maroteaux.
    Irfanullah ; Zeb A; Shinwari N; Shah K; Gilani SZT; Khan S; Lee KW; Raza SI; Hussain S; Liaqat K; Ahmad W
    Int J Biochem Cell Biol; 2018 Sep; 102():76-86. PubMed ID: 30016695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity.
    Nakao K; Kuwahara K; Nishikimi T; Nakagawa Y; Kinoshita H; Minami T; Kuwabara Y; Yamada C; Yamada Y; Tokudome T; Nagai-Okatani C; Minamino N; Nakao YM; Yasuno S; Ueshima K; Sone M; Kimura T; Kangawa K; Nakao K
    Hypertension; 2017 Feb; 69(2):286-296. PubMed ID: 28049696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-type natriuretic peptide as a new regulator of food intake and energy expenditure.
    Inuzuka M; Tamura N; Yamada N; Katsuura G; Oyamada N; Taura D; Sonoyama T; Fukunaga Y; Ohinata K; Sone M; Nakao K
    Endocrinology; 2010 Aug; 151(8):3633-42. PubMed ID: 20555027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation.
    Bocciardi R; Giorda R; Buttgereit J; Gimelli S; Divizia MT; Beri S; Garofalo S; Tavella S; Lerone M; Zuffardi O; Bader M; Ravazzolo R; Gimelli G
    Hum Mutat; 2007 Jul; 28(7):724-31. PubMed ID: 17373680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.
    Langenickel TH; Buttgereit J; Pagel-Langenickel I; Lindner M; Monti J; Beuerlein K; Al-Saadi N; Plehm R; Popova E; Tank J; Dietz R; Willenbrock R; Bader M
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4735-40. PubMed ID: 16537417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide.
    Thompson IR; Chand AN; King PJ; Ansorge O; Karavitaki N; Jones CA; Rahmutula D; Gardner DG; Zivkovic V; Wheeler-Jones CP; McGonnell IM; Korbonits M; Anderson RA; Wass JA; McNeilly AS; Fowkes RC
    Endocr Relat Cancer; 2012 Aug; 19(4):497-508. PubMed ID: 22645228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
    Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
    Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
    Abbey SE; Potter LR
    Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted disruption of C-type natriuretic peptide: a focused assault on cartilaginous bone.
    Centrella M; McCarthy TL
    Trends Endocrinol Metab; 2001 Aug; 12(6):235-6. PubMed ID: 11445430
    [No Abstract]   [Full Text] [Related]  

  • 58. Acromesomelic dysplasia Maroteaux-type in patients from Vietnam.
    Tran TH; Cao MH; Luong LH; Le PT; Vu DC; Ta TD; Bui TH; Nguyen DH; Van Ta T; Tran VK
    Am J Med Genet A; 2019 Aug; 179(8):1420-1422. PubMed ID: 31077548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological and Genetic Disruption of C-Type Natriuretic Peptide (
    Lessey AJ; Mirczuk SM; Chand AN; Kurrasch DM; Korbonits M; Niessen SJM; McArdle CA; McGonnell IM; Fowkes RC
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of vosoritide in the treatment of achondroplasia.
    Paton DM
    Drugs Today (Barc); 2022 Sep; 58(9):451-456. PubMed ID: 36102905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.